Usted buscó: astra zeneca (Portugués - Inglés)

astra zeneca ab
astra zeneca ab s-151 85 södertälje sweden

astra zeneca Österreich gmbh
astra zeneca Österreich gmbh schwarzenbergplatz 7 1037 wien

astra
astra

loratadin astra zeneca loratadin nm pharma
loratadin astra zeneca

astra ze neca
astra ze neca

processo n° iv/m. 1403 - astra/zeneca
11case n°iv/m.1403 — astra/zeneca

astra zeneca Österreich gmbh casodex schwarzenbergplatz 7 1037 wien
astra zeneca Österreich gmbh schwarzenbergplatz 7 1037 wien

knauf astra ltd.
knauf astra ltd

ad astra et vitra
ad astra et vitra

focus, astra, megane y
the technique to encrypt these messages is ssl.

por ex., focus, astra, megane
e.g. focus, astra, megane

opel astra 28,7% 23,0% 21,0
opel astra 28.7% 23.0% 21.0%

nv astra- zeneca sa rue egide van ophem straat, 110 b- 1180 brussels bélgica
nv astra-zeneca sa rue egide van ophem straat,110 b-1180 brussels belgium

opel astra/kadett 15,2% (23,9%)
opel astra/kadett 15.2% (23.9%)

a astrazeneca é o resultado de uma fusão operada em 1999 entre a empresa sueca astra ab e a empresa britânica zeneca plc.
astrazeneca is the product of a merger in 1999 between sweden's astra ab and the uk company zeneca plc.

o dr. calhoun atuou como consultor da novartis e recebeu apoio financeiro da novartis, merck, astra-zeneca e encysive pharmaceuticals.
dr. calhoun has served as a consultant for novartis; has received grant support from novartis, merck, astra-zeneca and encysive pharmaceuticals.

astrazeneca plc (, ) é um conglomerado farmacêutico criado em 6 de abril de 1999 pela fusão da companhia sueca astra ab e da britânica zeneca group.
the company was founded in 1999 through the merger of the sweden-based astra ab and the uk-based zeneca group (itself formed by the demerger of the pharmaceutical operations of imperial chemical industries in 1993).

a autora participou como investigadora nos estudos multicêntricos internacionais: optima 1998 e stay 2000 da astra-zeneca e estudo goal 2000 - glaxo smith kline.
the author participated as an investigator in the following international multicenter studies: optima 1998, astra-zeneca; stay 2000, astra-zeneca; and goal 2000, glaxo smith kline.

barbuti rc: recebeu honorários como palestrante, organização de atividades de ensino, realização de pesquisa e consultoria patrocinado pelas empresas astra zeneca, aché e medley.
barbut r.c. received founding for lectures, research, teaching organization, and consulting sponsored by astrazeneca, ache and medley.

dois grupos com sepse letal por k. pneumoniae esbl foram tratados com meropenem astra-zenecar.
two groups of esbl lethal sepsis were treated with meropenem astra-zenecar.